Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Immunotech Biopharm (6978 HK)
Watchlist
15
Analysis
Health Care
•
Hong Kong
Immunotech Biopharm Ltd operates as a biopharmaceutical company. The Company develops and produces cellular immunotherapy products and other products. Immunotech Biopharm markets its products throughout China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Immunotech Biopharm
•
23 Jun 2020 15:57
Immunotech Biopharm (永泰生物) IPO: Behind the Curve in Cell Therapy
Immunotech Biopharma, a cell therapy focused healthcare company, launched book building to raise up to USD 142 million to list in Hong Kong. In our...
Ke Yan, CFA, FRM
Follow
617 Views
Share
bullish
•
Legend Biotech Corp
•
19 May 2020 12:14
Legend Biotech (传奇生物) Pre-IPO: All-Stars Except for the Small Indication
Legend Biotech, a subsidiary of Hong Kong-listed GenScript, is planning to raise up to USD 300 million via an IPO. The company has a strong focus...
Ke Yan, CFA, FRM
Follow
194 Views
Share
bullish
•
AllHome Corp
•
07 Sep 2019 14:15
ECM Weekly (7 Sep 2019) - China Merchants Comm REIT, Immunotech Bio, Bank of Guizhou, XD, Huize
Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...
Zhen Zhou, Toh
539 Views
Share
bearish
•
Immunotech Biopharm
•
05 Sep 2019 16:48
Immunotech Biopharm (永泰生物) IPO: Challenges for Cellular Immunotherapies
Immunotech Biopharma, a leading cellular immunotherapy company in China, aims to raise USD 100 to 200 million via a Hong Kong listing. In this...
Ke Yan, CFA, FRM
Follow
796 Views
Share
First
Previous
1
2
3
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x